These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 37616338)
21. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome. Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562 [TBL] [Abstract][Full Text] [Related]
24. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome. Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430 [TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Xiao L; Liu Q; Luo M; Xiong L Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603 [TBL] [Abstract][Full Text] [Related]
26. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome. Singh P; Lembo A Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786 [TBL] [Abstract][Full Text] [Related]
27. Bile acid-gut microbiota crosstalk in irritable bowel syndrome. Gu Y; Li L; Yang M; Liu T; Song X; Qin X; Xu X; Liu J; Wang B; Cao H Crit Rev Microbiol; 2023 May; 49(3):350-369. PubMed ID: 35389754 [TBL] [Abstract][Full Text] [Related]
28. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Mujagic Z; Kasapi M; Jonkers DM; Garcia-Perez I; Vork L; Weerts ZZRM; Serrano-Contreras JI; Zhernakova A; Kurilshikov A; Scotcher J; Holmes E; Wijmenga C; Keszthelyi D; Nicholson JK; Posma JM; Masclee AA Gut Microbes; 2022; 14(1):2063016. PubMed ID: 35446234 [TBL] [Abstract][Full Text] [Related]
29. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156 [TBL] [Abstract][Full Text] [Related]
30. Comparison of five diarrhea-predominant irritable bowel syndrome (IBS-D) rat models in the brain-gut-microbiota axis. Wu H; Zhan K; Rao K; Zheng H; Qin S; Tang X; Huang S Biomed Pharmacother; 2022 May; 149():112811. PubMed ID: 35303570 [TBL] [Abstract][Full Text] [Related]
31. Ameliorative effects of chlorogenic acid on alcoholic liver injury in mice via gut microbiota informatics. Zhu H; Jiang W; Liu C; Wang C; Hu B; Guo Y; Cheng Y; Qian H Eur J Pharmacol; 2022 Aug; 928():175096. PubMed ID: 35697148 [TBL] [Abstract][Full Text] [Related]
33. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations? Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513 [TBL] [Abstract][Full Text] [Related]
34. Chlorogenic Acid-Induced Gut Microbiota Improves Metabolic Endotoxemia. Ye X; Liu Y; Hu J; Gao Y; Ma Y; Wen D Front Endocrinol (Lausanne); 2021; 12():762691. PubMed ID: 34975748 [TBL] [Abstract][Full Text] [Related]
35. Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome. Deng X; Xiao L; Luo M; Xie P; Xiong L J Gastroenterol Hepatol; 2023 Jul; 38(7):1072-1082. PubMed ID: 36869260 [TBL] [Abstract][Full Text] [Related]
36. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. Mei L; Zhou J; Su Y; Mao K; Wu J; Zhu C; He L; Cui Y BMC Gastroenterol; 2021 Mar; 21(1):105. PubMed ID: 33663411 [TBL] [Abstract][Full Text] [Related]
37. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873 [TBL] [Abstract][Full Text] [Related]
38. Fenchone Ameliorates Constipation-Predominant Irritable Bowel Syndrome via Modulation of SCF/c-Kit Pathway and Gut Microbiota. Cui L; Zhang B; Zou S; Liu J; Wang P; Li H; Zhang Z J Microbiol Biotechnol; 2024 Feb; 34(2):367-378. PubMed ID: 38073315 [TBL] [Abstract][Full Text] [Related]
39. Irritable bowel syndrome and gut microbiota. Canakis A; Haroon M; Weber HC Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Electroacupuncture in Alleviating Visceral Hypersensitivity in Post-Infectious Irritable Bowel Syndrome Mice: The Role of GDNF Signaling Pathway and Gut Microbiota. Jiang S; Pei L; Chen L; Sun J; Song Y Microb Physiol; 2024; 34(1):255-263. PubMed ID: 39396501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]